Publication:
Editorial: Women in psychiatry 2022: Psychopharmacology

dc.contributor.authorJan, Reem Kais
dc.date.accessioned2023-05-08T09:19:41Z
dc.date.available2023-05-08T09:19:41Z
dc.date.issued2023
dc.description.abstractIntroduction: Still a male-dominated field, science has often undervalued the work of women. We are not equally represented at higher career levels and face more professional obstacles than our male counterparts. One among many examples, Rosalind Franklin’s name is the first that come to mind. In the discovery of the DNA double helix, despite her crucial X-ray diffraction work, she never got the same recognition as her male counterparts Watson and Crick.en_US
dc.identifier.other204-2023.10
dc.identifier.urihttps://repository.mbru.ac.ae/handle/1/1242
dc.language.isoenen_US
dc.subjectWomenen_US
dc.subjectCocaineen_US
dc.subjectClozapineen_US
dc.subjectAntipsychoticen_US
dc.subjectEpigeneticsen_US
dc.subjectEscitalopramen_US
dc.subjectD3 Receptor Antagonisten_US
dc.titleEditorial: Women in psychiatry 2022: Psychopharmacologyen_US
dc.typeArticleen_US
dspace.entity.typePublicationen_US

Files